Author response: C-C chemokine receptor 4 deficiency exacerbates early atherosclerosis in mice Article Swipe

View

Toru Tanaka , Naoto Sasaki , Aga Krisnanda , Hilman Zulkifli Amin , Ken Ito , Sayo Horibe , Kazuhiko Matsuo , Ken-ichi Hirata , Takashi Nakayama , Yoshiyuki Rikitake ·

YOU? · · 2025 · Open Access · · DOI: https://doi.org/10.7554/elife.101830.2.sa0

Related Topics

Concepts

Chemokine Chemokine receptor Medicine Biology Receptor Internal medicine

Metadata

Type: peer-review
Language: en
Landing Page: https://doi.org/10.7554/elife.101830.2.sa0
OA Status: gold
Related Works: 10
OpenAlex ID: https://openalex.org/W4406863671

All OpenAlex metadata

Raw OpenAlex JSON

OpenAlex ID: https://openalex.org/W4406863671

Canonical identifier for this work in OpenAlex
DOI: https://doi.org/10.7554/elife.101830.2.sa0

Digital Object Identifier
Title: Author response: C-C chemokine receptor 4 deficiency exacerbates early atherosclerosis in mice

Work title
Type: peer-review

OpenAlex work type
Language: en

Primary language
Publication year: 2025

Year of publication
Publication date: 2025-01-27

Full publication date if available
Authors: Toru Tanaka, Naoto Sasaki, Aga Krisnanda, Hilman Zulkifli Amin, Ken Ito, Sayo Horibe, Kazuhiko Matsuo, Ken-ichi Hirata, Takashi Nakayama, Yoshiyuki Rikitake

List of authors in order
Landing page: https://doi.org/10.7554/elife.101830.2.sa0

Publisher landing page
Open access: Yes

Whether a free full text is available
OA status: gold

Open access status per OpenAlex
OA URL: https://doi.org/10.7554/elife.101830.2.sa0

Direct OA link when available
Concepts: Chemokine, Chemokine receptor, Medicine, Biology, Receptor, Internal medicine

Top concepts (fields/topics) attached by OpenAlex
Cited by: 0

Total citation count in OpenAlex
Related works (count): 10

Other works algorithmically related by OpenAlex

Full payload

id	https://openalex.org/W4406863671
doi	https://doi.org/10.7554/elife.101830.2.sa0
ids.doi	https://doi.org/10.7554/elife.101830.2.sa0
ids.openalex	https://openalex.org/W4406863671
fwci
type	peer-review
title	Author response: C-C chemokine receptor 4 deficiency exacerbates early atherosclerosis in mice
biblio.issue
biblio.volume
biblio.last_page
biblio.first_page
topics[0].id	https://openalex.org/T12955
topics[0].field.id	https://openalex.org/fields/24
topics[0].field.display_name	Immunology and Microbiology
topics[0].score	0.9868000149726868
topics[0].domain.id	https://openalex.org/domains/1
topics[0].domain.display_name	Life Sciences
topics[0].subfield.id	https://openalex.org/subfields/2403
topics[0].subfield.display_name	Immunology
topics[0].display_name	Atherosclerosis and Cardiovascular Diseases
topics[1].id	https://openalex.org/T11532
topics[1].field.id	https://openalex.org/fields/27
topics[1].field.display_name	Medicine
topics[1].score	0.9376999735832214
topics[1].domain.id	https://openalex.org/domains/4
topics[1].domain.display_name	Health Sciences
topics[1].subfield.id	https://openalex.org/subfields/2730
topics[1].subfield.display_name	Oncology
topics[1].display_name	Chemokine receptors and signaling
is_xpac	False
apc_list
apc_paid
concepts[0].id	https://openalex.org/C13373296
concepts[0].level	3
concepts[0].score	0.6125783324241638
concepts[0].wikidata	https://www.wikidata.org/wiki/Q421866
concepts[0].display_name	Chemokine
concepts[1].id	https://openalex.org/C12823836
concepts[1].level	4
concepts[1].score	0.5121068954467773
concepts[1].wikidata	https://www.wikidata.org/wiki/Q24720618
concepts[1].display_name	Chemokine receptor
concepts[2].id	https://openalex.org/C71924100
concepts[2].level	0
concepts[2].score	0.3706023693084717
concepts[2].wikidata	https://www.wikidata.org/wiki/Q11190
concepts[2].display_name	Medicine
concepts[3].id	https://openalex.org/C86803240
concepts[3].level	0
concepts[3].score	0.3690137267112732
concepts[3].wikidata	https://www.wikidata.org/wiki/Q420
concepts[3].display_name	Biology
concepts[4].id	https://openalex.org/C170493617
concepts[4].level	2
concepts[4].score	0.3390503525733948
concepts[4].wikidata	https://www.wikidata.org/wiki/Q208467
concepts[4].display_name	Receptor
concepts[5].id	https://openalex.org/C126322002
concepts[5].level	1
concepts[5].score	0.27133917808532715
concepts[5].wikidata	https://www.wikidata.org/wiki/Q11180
concepts[5].display_name	Internal medicine
keywords[0].id	https://openalex.org/keywords/chemokine
keywords[0].score	0.6125783324241638
keywords[0].display_name	Chemokine
keywords[1].id	https://openalex.org/keywords/chemokine-receptor
keywords[1].score	0.5121068954467773
keywords[1].display_name	Chemokine receptor
keywords[2].id	https://openalex.org/keywords/medicine
keywords[2].score	0.3706023693084717
keywords[2].display_name	Medicine
keywords[3].id	https://openalex.org/keywords/biology
keywords[3].score	0.3690137267112732
keywords[3].display_name	Biology
keywords[4].id	https://openalex.org/keywords/receptor
keywords[4].score	0.3390503525733948
keywords[4].display_name	Receptor
keywords[5].id	https://openalex.org/keywords/internal-medicine
keywords[5].score	0.27133917808532715
keywords[5].display_name	Internal medicine
language	en
locations[0].id	doi:10.7554/elife.101830.2.sa0
locations[0].is_oa	True
locations[0].source
locations[0].license	cc-by
locations[0].pdf_url
locations[0].version	publishedVersion
locations[0].raw_type	peer-review
locations[0].license_id	https://openalex.org/licenses/cc-by
locations[0].is_accepted	True
locations[0].is_published	True
locations[0].raw_source_name
locations[0].landing_page_url	https://doi.org/10.7554/elife.101830.2.sa0
indexed_in	crossref
authorships[0].author.id	https://openalex.org/A5101471439
authorships[0].author.orcid	https://orcid.org/0000-0002-1054-9211
authorships[0].author.display_name	Toru Tanaka
authorships[0].countries	JP
authorships[0].affiliations[0].institution_ids	https://openalex.org/I197065826
authorships[0].affiliations[0].raw_affiliation_string	Laboratory of Medical Pharmaceutics, Kobe Pharmaceutical University
authorships[0].institutions[0].id	https://openalex.org/I197065826
authorships[0].institutions[0].ror	https://ror.org/00088z429
authorships[0].institutions[0].type	education
authorships[0].institutions[0].lineage	https://openalex.org/I197065826
authorships[0].institutions[0].country_code	JP
authorships[0].institutions[0].display_name	Kobe Pharmaceutical University
authorships[0].author_position	first
authorships[0].raw_author_name	Toru Tanaka
authorships[0].is_corresponding	False
authorships[0].raw_affiliation_strings	Laboratory of Medical Pharmaceutics, Kobe Pharmaceutical University
authorships[1].author.id	https://openalex.org/A5074352632
authorships[1].author.orcid	https://orcid.org/0000-0002-7760-6129
authorships[1].author.display_name	Naoto Sasaki
authorships[1].countries	JP
authorships[1].affiliations[0].institution_ids	https://openalex.org/I197065826
authorships[1].affiliations[0].raw_affiliation_string	Laboratory of Medical Pharmaceutics, Kobe Pharmaceutical University
authorships[1].institutions[0].id	https://openalex.org/I197065826
authorships[1].institutions[0].ror	https://ror.org/00088z429
authorships[1].institutions[0].type	education
authorships[1].institutions[0].lineage	https://openalex.org/I197065826
authorships[1].institutions[0].country_code	JP
authorships[1].institutions[0].display_name	Kobe Pharmaceutical University
authorships[1].author_position	middle
authorships[1].raw_author_name	Naoto Sasaki
authorships[1].is_corresponding	False
authorships[1].raw_affiliation_strings	Laboratory of Medical Pharmaceutics, Kobe Pharmaceutical University
authorships[2].author.id	https://openalex.org/A5093710095
authorships[2].author.orcid	https://orcid.org/0009-0005-6417-2738
authorships[2].author.display_name	Aga Krisnanda
authorships[2].countries	JP
authorships[2].affiliations[0].institution_ids	https://openalex.org/I197065826
authorships[2].affiliations[0].raw_affiliation_string	Laboratory of Medical Pharmaceutics, Kobe Pharmaceutical University
authorships[2].institutions[0].id	https://openalex.org/I197065826
authorships[2].institutions[0].ror	https://ror.org/00088z429
authorships[2].institutions[0].type	education
authorships[2].institutions[0].lineage	https://openalex.org/I197065826
authorships[2].institutions[0].country_code	JP
authorships[2].institutions[0].display_name	Kobe Pharmaceutical University
authorships[2].author_position	middle
authorships[2].raw_author_name	Aga Krisnanda
authorships[2].is_corresponding	False
authorships[2].raw_affiliation_strings	Laboratory of Medical Pharmaceutics, Kobe Pharmaceutical University
authorships[3].author.id	https://openalex.org/A5058335036
authorships[3].author.orcid	https://orcid.org/0000-0003-0659-9678
authorships[3].author.display_name	Hilman Zulkifli Amin
authorships[3].countries	JP
authorships[3].affiliations[0].institution_ids	https://openalex.org/I197065826
authorships[3].affiliations[0].raw_affiliation_string	Laboratory of Medical Pharmaceutics, Kobe Pharmaceutical University
authorships[3].institutions[0].id	https://openalex.org/I197065826
authorships[3].institutions[0].ror	https://ror.org/00088z429
authorships[3].institutions[0].type	education
authorships[3].institutions[0].lineage	https://openalex.org/I197065826
authorships[3].institutions[0].country_code	JP
authorships[3].institutions[0].display_name	Kobe Pharmaceutical University
authorships[3].author_position	middle
authorships[3].raw_author_name	Hilman Zulkifli Amin
authorships[3].is_corresponding	False
authorships[3].raw_affiliation_strings	Laboratory of Medical Pharmaceutics, Kobe Pharmaceutical University
authorships[4].author.id	https://openalex.org/A5103157888
authorships[4].author.orcid	https://orcid.org/0009-0007-8678-1862
authorships[4].author.display_name	Ken Ito
authorships[4].countries	JP
authorships[4].affiliations[0].institution_ids	https://openalex.org/I197065826
authorships[4].affiliations[0].raw_affiliation_string	Laboratory of Medical Pharmaceutics, Kobe Pharmaceutical University
authorships[4].institutions[0].id	https://openalex.org/I197065826
authorships[4].institutions[0].ror	https://ror.org/00088z429
authorships[4].institutions[0].type	education
authorships[4].institutions[0].lineage	https://openalex.org/I197065826
authorships[4].institutions[0].country_code	JP
authorships[4].institutions[0].display_name	Kobe Pharmaceutical University
authorships[4].author_position	middle
authorships[4].raw_author_name	Ken Ito
authorships[4].is_corresponding	False
authorships[4].raw_affiliation_strings	Laboratory of Medical Pharmaceutics, Kobe Pharmaceutical University
authorships[5].author.id	https://openalex.org/A5091273722
authorships[5].author.orcid	https://orcid.org/0000-0002-4111-2426
authorships[5].author.display_name	Sayo Horibe
authorships[5].countries	JP
authorships[5].affiliations[0].institution_ids	https://openalex.org/I197065826
authorships[5].affiliations[0].raw_affiliation_string	Laboratory of Medical Pharmaceutics, Kobe Pharmaceutical University
authorships[5].institutions[0].id	https://openalex.org/I197065826
authorships[5].institutions[0].ror	https://ror.org/00088z429
authorships[5].institutions[0].type	education
authorships[5].institutions[0].lineage	https://openalex.org/I197065826
authorships[5].institutions[0].country_code	JP
authorships[5].institutions[0].display_name	Kobe Pharmaceutical University
authorships[5].author_position	middle
authorships[5].raw_author_name	Sayo Horibe
authorships[5].is_corresponding	False
authorships[5].raw_affiliation_strings	Laboratory of Medical Pharmaceutics, Kobe Pharmaceutical University
authorships[6].author.id	https://openalex.org/A5101747943
authorships[6].author.orcid	https://orcid.org/0000-0001-5782-5300
authorships[6].author.display_name	Kazuhiko Matsuo
authorships[6].countries	JP
authorships[6].affiliations[0].institution_ids	https://openalex.org/I916559398
authorships[6].affiliations[0].raw_affiliation_string	Division of Chemotherapy, Faculty of Pharmacy, Kindai University
authorships[6].institutions[0].id	https://openalex.org/I916559398
authorships[6].institutions[0].ror	https://ror.org/05kt9ap64
authorships[6].institutions[0].type	education
authorships[6].institutions[0].lineage	https://openalex.org/I916559398
authorships[6].institutions[0].country_code	JP
authorships[6].institutions[0].display_name	Kindai University
authorships[6].author_position	middle
authorships[6].raw_author_name	Kazuhiko Matsuo
authorships[6].is_corresponding	False
authorships[6].raw_affiliation_strings	Division of Chemotherapy, Faculty of Pharmacy, Kindai University
authorships[7].author.id	https://openalex.org/A5112266909
authorships[7].author.orcid
authorships[7].author.display_name	Ken-ichi Hirata
authorships[7].countries	JP
authorships[7].affiliations[0].institution_ids	https://openalex.org/I65837984
authorships[7].affiliations[0].raw_affiliation_string	Division of Cardiovascular Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine
authorships[7].institutions[0].id	https://openalex.org/I65837984
authorships[7].institutions[0].ror	https://ror.org/03tgsfw79
authorships[7].institutions[0].type	education
authorships[7].institutions[0].lineage	https://openalex.org/I65837984
authorships[7].institutions[0].country_code	JP
authorships[7].institutions[0].display_name	Kobe University
authorships[7].author_position	middle
authorships[7].raw_author_name	Ken-ichi Hirata
authorships[7].is_corresponding	False
authorships[7].raw_affiliation_strings	Division of Cardiovascular Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine
authorships[8].author.id	https://openalex.org/A5080136320
authorships[8].author.orcid	https://orcid.org/0000-0002-8493-899X
authorships[8].author.display_name	Takashi Nakayama
authorships[8].countries	JP
authorships[8].affiliations[0].institution_ids	https://openalex.org/I916559398
authorships[8].affiliations[0].raw_affiliation_string	Division of Chemotherapy, Faculty of Pharmacy, Kindai University
authorships[8].institutions[0].id	https://openalex.org/I916559398
authorships[8].institutions[0].ror	https://ror.org/05kt9ap64
authorships[8].institutions[0].type	education
authorships[8].institutions[0].lineage	https://openalex.org/I916559398
authorships[8].institutions[0].country_code	JP
authorships[8].institutions[0].display_name	Kindai University
authorships[8].author_position	middle
authorships[8].raw_author_name	Takashi Nakayama
authorships[8].is_corresponding	False
authorships[8].raw_affiliation_strings	Division of Chemotherapy, Faculty of Pharmacy, Kindai University
authorships[9].author.id	https://openalex.org/A5003538048
authorships[9].author.orcid	https://orcid.org/0000-0001-7207-4656
authorships[9].author.display_name	Yoshiyuki Rikitake
authorships[9].countries	JP
authorships[9].affiliations[0].institution_ids	https://openalex.org/I197065826
authorships[9].affiliations[0].raw_affiliation_string	Laboratory of Medical Pharmaceutics, Kobe Pharmaceutical University
authorships[9].institutions[0].id	https://openalex.org/I197065826
authorships[9].institutions[0].ror	https://ror.org/00088z429
authorships[9].institutions[0].type	education
authorships[9].institutions[0].lineage	https://openalex.org/I197065826
authorships[9].institutions[0].country_code	JP
authorships[9].institutions[0].display_name	Kobe Pharmaceutical University
authorships[9].author_position	last
authorships[9].raw_author_name	Yoshiyuki Rikitake
authorships[9].is_corresponding	False
authorships[9].raw_affiliation_strings	Laboratory of Medical Pharmaceutics, Kobe Pharmaceutical University
has_content.pdf	False
has_content.grobid_xml	False
is_paratext	False
open_access.is_oa	True
open_access.oa_url	https://doi.org/10.7554/elife.101830.2.sa0
open_access.oa_status	gold
open_access.any_repository_has_fulltext	False
created_date	2025-10-10T00:00:00
display_name	Author response: C-C chemokine receptor 4 deficiency exacerbates early atherosclerosis in mice
has_fulltext	False
is_retracted	False
updated_date	2025-11-06T03:46:38.306776
primary_topic.id	https://openalex.org/T12955
primary_topic.field.id	https://openalex.org/fields/24
primary_topic.field.display_name	Immunology and Microbiology
primary_topic.score	0.9868000149726868
primary_topic.domain.id	https://openalex.org/domains/1
primary_topic.domain.display_name	Life Sciences
primary_topic.subfield.id	https://openalex.org/subfields/2403
primary_topic.subfield.display_name	Immunology
primary_topic.display_name	Atherosclerosis and Cardiovascular Diseases
related_works	https://openalex.org/W2289050973, https://openalex.org/W2959910393, https://openalex.org/W2130609179, https://openalex.org/W1969457460, https://openalex.org/W1496753157, https://openalex.org/W2014896342, https://openalex.org/W4230420183, https://openalex.org/W2049037034, https://openalex.org/W1980371805, https://openalex.org/W1966564905
cited_by_count	0
locations_count	1
best_oa_location.id	doi:10.7554/elife.101830.2.sa0
best_oa_location.is_oa	True
best_oa_location.source
best_oa_location.license	cc-by
best_oa_location.pdf_url
best_oa_location.version	publishedVersion
best_oa_location.raw_type	peer-review
best_oa_location.license_id	https://openalex.org/licenses/cc-by
best_oa_location.is_accepted	True
best_oa_location.is_published	True
best_oa_location.raw_source_name
best_oa_location.landing_page_url	https://doi.org/10.7554/elife.101830.2.sa0
primary_location.id	doi:10.7554/elife.101830.2.sa0
primary_location.is_oa	True
primary_location.source
primary_location.license	cc-by
primary_location.pdf_url
primary_location.version	publishedVersion
primary_location.raw_type	peer-review
primary_location.license_id	https://openalex.org/licenses/cc-by
primary_location.is_accepted	True
primary_location.is_published	True
primary_location.raw_source_name
primary_location.landing_page_url	https://doi.org/10.7554/elife.101830.2.sa0
publication_date	2025-01-27
publication_year	2025
referenced_works_count	0
abstract_inverted_index
cited_by_percentile_year
countries_distinct_count	1
institutions_distinct_count	10
citation_normalized_percentile